Correlation Between Sprint Bioscience and Enzymatica Publ
Can any of the company-specific risk be diversified away by investing in both Sprint Bioscience and Enzymatica Publ at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprint Bioscience and Enzymatica Publ into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sprint Bioscience AB and Enzymatica publ AB, you can compare the effects of market volatilities on Sprint Bioscience and Enzymatica Publ and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprint Bioscience with a short position of Enzymatica Publ. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprint Bioscience and Enzymatica Publ.
Diversification Opportunities for Sprint Bioscience and Enzymatica Publ
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Sprint and Enzymatica is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Sprint Bioscience AB and Enzymatica publ AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzymatica publ AB and Sprint Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprint Bioscience AB are associated (or correlated) with Enzymatica Publ. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzymatica publ AB has no effect on the direction of Sprint Bioscience i.e., Sprint Bioscience and Enzymatica Publ go up and down completely randomly.
Pair Corralation between Sprint Bioscience and Enzymatica Publ
Assuming the 90 days trading horizon Sprint Bioscience AB is expected to generate 0.8 times more return on investment than Enzymatica Publ. However, Sprint Bioscience AB is 1.25 times less risky than Enzymatica Publ. It trades about 0.09 of its potential returns per unit of risk. Enzymatica publ AB is currently generating about -0.06 per unit of risk. If you would invest 125.00 in Sprint Bioscience AB on September 1, 2024 and sell it today you would earn a total of 57.00 from holding Sprint Bioscience AB or generate 45.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sprint Bioscience AB vs. Enzymatica publ AB
Performance |
| Timeline |
| Sprint Bioscience |
| Enzymatica publ AB |
Sprint Bioscience and Enzymatica Publ Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sprint Bioscience and Enzymatica Publ
The main advantage of trading using opposite Sprint Bioscience and Enzymatica Publ positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprint Bioscience position performs unexpectedly, Enzymatica Publ can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzymatica Publ will offset losses from the drop in Enzymatica Publ's long position.| Sprint Bioscience vs. Kancera AB | Sprint Bioscience vs. Cyxone AB | Sprint Bioscience vs. Lidds AB | Sprint Bioscience vs. Cantargia AB |
| Enzymatica Publ vs. Oncopeptides AB | Enzymatica Publ vs. Diamyd Medical AB | Enzymatica Publ vs. Kancera AB | Enzymatica Publ vs. Bonesupport Holding AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |